Western WIA Stock Consolidating at 821 Next Move Ahead 20260514 Iterum ITRM Stalls at 003 Consolidation Phase 20260515 Turkey and Kazakhstan Deepen Strategic Partnership with 13 Billion Trade Target Perimeter PRM Jumps 080 on Strong Momentum 20260518 Goldman Sachs Poised for Lead Underwriter Role in SpaceX IPO Source Confirms Emera EMA Rallies 074 as Bulls Target 5545 20260520 Somnigroup International SGI Q1 2026 Earnings Surprise EPS 059 Up Significant Ondas ONDS Q1 2026 Earnings Miss by Significant Key Takeaways AsiaPacific Markets Poised for Broad Gains as Oil Retreats on USIran Peace Hopes Global Leaders Watch Closely as TrumpXi Summit Approaches International Aid Sector Faces Structural Pressures as Overhead Costs Under Scrutiny Analysis Suggests Logan Paul Crypto Speculators and MillionDollar Cards The Investment Frenzy Driving the Pokmon Market TFCI Gains Attention as JhunjhunwalaPartnered Fund Acquires Stake MD Shares Business Outlook Eli Lilly Stock Edges Higher on Nearly 4 Billion Vaccine Push into Infectious Disease RD NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower YHGJ Q4 2023 Earnings Positive EPS Lifts Stock Despite Sparse Data PNNT Q1 2026 Earnings Earnings Miss Amid Stable Portfolio Performance AC Immune Q1 2026 Earnings EPS Slightly Beats Estimates Amid PreRevenue Stage CTNM Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Pipeline Advances Salesforce Receives Mixed Analyst Reviews Deutsche Bank Maintains Positive Outlook While Citi Adjusts Price Target Altimmune Inc ALT Q1 2026 Earnings EPS Beat Surprises to the Upside Amid Pipeline Progress Nvidia and Asias Semiconductor Titans Ride the AI Gold Rush Delivery Hero Shares Surge as Uber Reportedly Eyes 33 Per Share Takeover Bid European Firms Shift to Reindustrialisation as Investment Plans Contract Workday Stock Rises on Upbeat Margin Forecast Amid AI Success Cathie Woods Ark Invest Points to Cryptocurrency With 930 Upside Potential Market Context BristolMyers Squibb BMY Dividend Appeal Hedge Fund View and AI Collaboration Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Performance